These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 903880)

  • 1. Synthesis of 10alpha-methoxy-delta8,9-lysergaldehyde from elymoclavine.
    Choong TC; Thompson BL; Shough HR
    J Pharm Sci; 1977 Sep; 66(9):1340-1. PubMed ID: 903880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH; Milhahn H; Eich E
    J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis of glycosides and sugar orthoesters of 9,10-dihydrolysergol].
    Seifert K; Johne S
    Arch Pharm (Weinheim); 1984 Jul; 317(7):577-83. PubMed ID: 6487053
    [No Abstract]   [Full Text] [Related]  

  • 4. Total synthesis of (+/-)-lysergic acid, lysergol, and isolysergol by palladium-catalyzed domino cyclization of amino allenes bearing a bromoindolyl group.
    Inuki S; Oishi S; Fujii N; Ohno H
    Org Lett; 2008 Nov; 10(22):5239-42. PubMed ID: 18956869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselective total synthesis of (+)-lysergic acid, (+)-lysergol, and (+)-isolysergol by palladium-catalyzed domino cyclization of allenes bearing amino and bromoindolyl groups.
    Inuki S; Iwata A; Oishi S; Fujii N; Ohno H
    J Org Chem; 2011 Apr; 76(7):2072-83. PubMed ID: 21361331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential central nervous system antineoplastic agents. Amides of 6-cyano-6-norlysergic acid.
    Portlock DE; Schwarzel WC; Ghosh AC; Dalzell HC; Razdan RK
    J Med Chem; 1975 Jul; 18(7):764-5. PubMed ID: 1151999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convenient synthesis of 6-nor-9,10-dihydrolysergic acid methyl ester.
    Crider AM; Grubb R; Bachmann KA; Rawat AK
    J Pharm Sci; 1981 Dec; 70(12):1319-21. PubMed ID: 7198684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioefficient synthesis of alpha-ergocryptine: first direct synthesis of (+)-lysergic acid.
    Moldvai I; Temesvári-Major E; Incze M; Szentirmay E; Gács-Baitz E; Szántay C
    J Org Chem; 2004 Sep; 69(18):5993-6000. PubMed ID: 15373483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reported "new synthesis of lysergic acid" yields only the derailment product: methyl 5-methoxy-4,5-dihydroindolo[4,3-f,g]quinoline-9-carboxylate.
    Bekkam M; Mo H; Nichols DE
    Org Lett; 2012 Jan; 14(1):296-8. PubMed ID: 22176338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formal total synthesis of (+)-lysergic acid via zinc(II)-mediated regioselective ring-opening reduction of 2-alkynyl-3-indolyloxirane.
    Iwata A; Inuki S; Oishi S; Fujii N; Ohno H
    J Org Chem; 2011 Jul; 76(13):5506-12. PubMed ID: 21598967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ergot alkaloids. Synthesis of 6-methyl-8-ergolenes as inhibitors of prolactin release.
    Li GS; Robinson JM; Floss HG; Cassady JM
    J Med Chem; 1975 Sep; 18(9):892-5. PubMed ID: 1159711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergot alkaloids. Synthesis of nitrosourea derivatives of ergolines as potential anticancer agents.
    Crider AM; Lu CK; Floss HG; Cassady JM; Clemens JA
    J Med Chem; 1979 Jan; 22(1):32-5. PubMed ID: 423180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of (+)-Lysergol and Its Analogues To Assess Serotonin Receptor Activity.
    Yuan H; Guo Z; Luo T
    Org Lett; 2017 Feb; 19(3):624-627. PubMed ID: 28106398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring clavines: antagonism/partial agonism at 5-HT2A receptors and antagonism at alpha 1-adrenoceptors in blood vessels.
    Pertz H
    Planta Med; 1996 Oct; 62(5):387-92. PubMed ID: 8923801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total synthesis of (+)-lysergic acid.
    Liu Q; Jia Y
    Org Lett; 2011 Sep; 13(18):4810-3. PubMed ID: 21866948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis of lysergic acid.
    Umezaki S; Yokoshima S; Fukuyama T
    Org Lett; 2013 Aug; 15(16):4230-3. PubMed ID: 23919892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational study of lysergic acid derivatives in relation to their hallucinogenic and antiserotonin activities.
    Kumbar M
    NIDA Res Monogr; 1978; (22):374-407. PubMed ID: 101885
    [No Abstract]   [Full Text] [Related]  

  • 18. Total synthesis of (+)-lysergic acid.
    Liu Q; Zhang YA; Xu P; Jia Y
    J Org Chem; 2013 Nov; 78(21):10885-93. PubMed ID: 24111583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emetic activity of reduced lysergamides.
    Johnson FN; Ary IE; Teiger DG; Kassel RJ
    J Med Chem; 1973 May; 16(5):532-7. PubMed ID: 4718471
    [No Abstract]   [Full Text] [Related]  

  • 20. Total synthesis of (+)-lysergic acid.
    Kanno R; Yokoshima S; Kanai M; Fukuyama T
    J Antibiot (Tokyo); 2018 Feb; 71(2):240-247. PubMed ID: 29375135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.